Exjade (Page 9 of 9)
PRINCIPAL DISPLAY PANEL
NDC 0078-0468-15 Rx only
EXJADE®
(deferasirox)
Tablets for Oral Suspension*
125 mg per tablet
PHARMACIST: Dispense with accompanyingMedication Guide to each patient.
DO NOT CHEW OR SWALLOW WHOLE
*Tablets MUST be dispersed in water,
orange or apple juice prior to ingestion.
NOVARTIS 30 Tablets
PRINCIPAL DISPLAY PANEL
NDC 0078-0469-15 Rx only
EXJADE®
(deferasirox)
Tablets for Oral Suspension*
250 mg per tablet
PHARMACIST: Dispense with accompanyingMedication Guide to each patient.
DO NOT CHEW OR SWALLOW WHOLE
*Tablets MUST be dispersed in water,
orange or apple juice prior to ingestion.
NOVARTIS 30 Tablets
PRINCIPAL DISPLAY PANEL
NDC 0078-0470-15 Rx only
EXJADE®
(deferasirox)
Tablets for Oral Suspension*
500 mg per tablet
PHARMACIST: Dispense with accompanyingMedication Guide to each patient.
DO NOT CHEW OR SWALLOW WHOLE
*Tablets MUST be dispersed in water,
orange or apple juice prior to ingestion.
NOVARTIS 30 Tablets
EXJADE deferasirox tablet, for suspension | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
EXJADE deferasirox tablet, for suspension | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
EXJADE deferasirox tablet, for suspension | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — Novartis Pharmaceuticals Corporation (002147023) |
Revised: 08/2023 Novartis Pharmaceuticals Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.